PepGen Inc. (PEPG) stock
PEPGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.83−0.05 (-1.29%)
Close on Nov 18, 2026Market cap $265.26MP/E –Yield –
PepGen net income
Net income is the profit left for shareholders after every expense, interest and tax.
PepGen's net income for the twelve months ending Jun 30, 2026 was -$71.94M. For fiscal 2025 it was -$89.66M. The highest annual figure on record is -$27.28M in fiscal 2021.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$89.66M | – |
| FY2024 | Dec 31, 2024 | -$89.98M | – |
| FY2023 | Dec 31, 2023 | -$78.63M | – |
| FY2022 | Dec 31, 2022 | -$69.10M | – |
| FY2021 | Dec 31, 2021 | -$27.28M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.81M | – |
| Q1 FY2026 | Mar 31, 2026 | -$17.76M | – |
| Q4 FY2025 | Dec 31, 2025 | -$18.34M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.03M | – |
| Q2 FY2025 | Jun 30, 2025 | -$23.09M | – |
| Q1 FY2025 | Mar 31, 2025 | -$30.20M | – |
| Q4 FY2024 | Dec 31, 2024 | -$22.24M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.38M | – |
| Q2 FY2024 | Jun 30, 2024 | -$28.34M | – |
| Q1 FY2024 | Mar 31, 2024 | -$18.02M | – |
| Q4 FY2023 | Dec 31, 2023 | -$19.50M | – |
| Q3 FY2023 | Sep 30, 2023 | -$23.29M | – |
| Q2 FY2023 | Jun 30, 2023 | -$19.52M | – |
| Q1 FY2023 | Mar 31, 2023 | -$16.32M | – |
| Q4 FY2022 | Dec 31, 2022 | -$14.94M | – |
| Q3 FY2022 | Sep 30, 2022 | -$18.61M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.32M | – |
| Q1 FY2022 | Mar 31, 2022 | -$18.25M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.14M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.11M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.39M | – |
| Q1 FY2021 | Mar 31, 2021 | -$6.64M | – |
See a number that looks wrong?